Bodal Chemicals Limited (IN:BODALCHEM)
:BODALCHEM
Top Page
Bodal Chemicals Limited
(BODALCHEM)
Select Model
Select Model
Rating:56Neutral
Price Target:
₹67.00
▲(23.94% Upside)
Action:ReiteratedDate:04/09/26
The score is held back mainly by weak profitability and negative free cash flow, plus an extremely high P/E valuation. Technicals are supportive due to an ongoing uptrend, but overbought momentum indicators add risk.
Positive Factors
Revenue Growth
Sustained double-digit top-line growth expands scale and supports longer-term investment in specialty product lines. Over 2-6 months this growth underpins bargaining leverage with suppliers, improves fixed-cost absorption, and increases optionality to shift mix toward higher-margin specialties.
Negative Factors
Weak Net Profitability
Very low net margins and ROE indicate the company struggles to translate sales into shareholder returns. Over the medium term this constrains retained earnings, limits ability to self-fund growth, and raises sensitivity to cost shocks or pricing pressure in the textile chemicals market.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained double-digit top-line growth expands scale and supports longer-term investment in specialty product lines. Over 2-6 months this growth underpins bargaining leverage with suppliers, improves fixed-cost absorption, and increases optionality to shift mix toward higher-margin specialties.
Read all positive factors
Bodal Chemicals Limited (BODALCHEM) vs. iShares MSCI India ETF (INDA)
Market Cap
₹8.15B
Dividend YieldN/A
Average Volume (3M)9.69K
Price to Earnings (P/E)697.5
Beta (1Y)1.39
Revenue Growth15.56%
EPS Growth2114.71%
CountryIN
Employees2,133
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)0.02
Shares Outstanding125,944,060
10 Day Avg. Volume13,655
30 Day Avg. Volume9,685
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)0.70
Price to Sales (P/S)0.45
P/FCF Ratio-93.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)7.1
Revenue Forecast (FY)₹22.23B
Bodal Chemicals Limited Business Overview & Revenue Model
Company Description
Bodal Chemicals Limited manufactures and sells dyestuffs, dyes intermediates, and other chemicals in India. The company's dye intermediates primarily include vinyl sulphone ester, ortho anisidine vinyl sulphone, meta ureido aniline, H. acid, Bronn...
How the Company Makes Money
Bodal Chemicals makes money primarily by manufacturing and selling chemical products, with revenue largely driven by (1) sales of dyes (finished colorants sold to textile processors and other industrial users) and (2) sales of dye intermediates (c...
Bodal Chemicals Limited Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
70
Positive
Cash Flow
55
Neutral
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.29B | 17.45B | 13.95B | 15.63B | 20.27B | 12.21B |
| Gross Profit | 8.38B | 6.76B | 1.68B | 6.70B | 5.42B | 3.29B |
| EBITDA | 1.89B | 1.69B | 1.19B | 1.45B | 2.16B | 1.00B |
| Net Income | 354.45M | 185.02M | 64.69M | 380.33M | 1.04B | 419.82M |
Balance Sheet | ||||||
| Total Assets | 23.13B | 23.53B | 22.88B | 21.21B | 21.22B | 17.48B |
| Cash, Cash Equivalents and Short-Term Investments | 391.00M | 360.60M | 462.50M | 225.87M | 93.95M | 119.14M |
| Total Debt | 8.66B | 9.11B | 8.47B | 6.98B | 5.76B | 3.47B |
| Total Liabilities | 11.91B | 12.48B | 12.06B | 10.43B | 10.70B | 7.68B |
| Stockholders Equity | 11.22B | 11.05B | 10.82B | 10.78B | 10.56B | 9.81B |
Cash Flow | ||||||
| Free Cash Flow | 587.21M | -83.36M | -407.19M | -528.49M | -1.73B | -1.91B |
| Operating Cash Flow | 778.82M | 381.14M | 2.04B | 2.85B | -135.20M | -130.17M |
| Investing Cash Flow | 75.41M | -424.34M | -2.62B | -3.10B | -1.70B | -1.68B |
| Financing Cash Flow | -920.92M | 76.36M | 809.81M | 326.55M | 1.81B | 1.78B |
Bodal Chemicals Limited Technical Analysis
Positive
54.06
Price Trends
49.99
Positive
51.40
Positive
59.52
Positive
Market Momentum
4.10
Negative
72.58
Negative
84.47
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BODALCHEM, the sentiment is Positive. The current price of 54.06 is above the 20-day moving average (MA) of 52.73, above the 50-day MA of 49.99, and below the 200-day MA of 59.52, indicating a bullish trend. The MACD of 4.10 indicates Negative momentum. The RSI at 72.58 is Negative, neither overbought nor oversold. The STOCH value of 84.47 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:BODALCHEM.
Bodal Chemicals Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ₹7.03B | 17.61 | ― | 0.81% | 33.39% | 85.08% | |
62 Neutral | ₹10.93B | 17.66 | ― | 0.52% | 28.67% | 50.12% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | ₹5.99B | 95.10 | ― | 0.45% | -4.09% | -32.35% | |
57 Neutral | ₹24.35B | 0.22 | ― | ― | -22.04% | -58.81% | |
56 Neutral | ₹8.15B | 697.51 | ― | ― | 15.56% | 2114.71% | |
46 Neutral | ₹6.48B | -2,425.33 | ― | 1.07% | -22.10% | -85.56% |
* Basic Materials Sector Average
IN:BODALCHEM
Bodal Chemicals Limited
64.75
4.63
7.70%
IN:AGARIND
Agarwal Industrial Corporation Limited
404.15
-575.41
-58.74%
IN:BHAGERIA
Bhageria Industries Ltd.
161.15
7.28
4.73%
IN:FAIRCHEMOR
Fairchem Organics Ltd
514.55
-341.28
-39.88%
IN:KIRIINDUS
Kiri Industries Limited
405.65
-216.65
-34.81%
IN:SHREEPUSHK
Shree Pushkar Chemicals & Fertilisers Ltd.
338.10
107.22
46.44%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.